BEGIN:VCALENDAR VERSION:2.0 PRODID:-//IBSAL - ECPv6.17.2//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:IBSAL X-ORIGINAL-URL:https://ibsal.es/en/ X-WR-CALDESC:Events for IBSAL REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD TZOFFSETFROM:+0000 TZOFFSETTO:+0000 TZNAME:UTC DTSTART:20240101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Europe/Helsinki BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20250330T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20251026T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20260329T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20261025T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20270328T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20271031T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0200 TZOFFSETTO:+0300 TZNAME:EEST DTSTART:20280326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET DTSTART:20281029T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20250326 DTEND;VALUE=DATE:20300604 DTSTAMP:20251114T074015Z CREATED:20250304T093623Z LAST-MODIFIED:20251114T074015Z UID:10002030-1742947200-1906761599@ibsal.es SUMMARY:Diverse and responsible health DESCRIPTION:The project “Diverse and Responsible Health” aims at the scientific dissemination of the IBSAL among the LGTBI+ population of Salamanca. Through a series of workshops scheduled throughout 2025\, various key issues for the health of this group will be addressed\, promoting a gender and diversity perspective in medical and scientific research. \nThese workshops\, led by the Eros Service of Asociación Iguales\, will have the participation of specialized professionals\, IBSAL research staff and collaborating entities. The program includes four sessions with the following topics: \n\n\n\n\nITS: Why do they always point the finger at us? – Analysis of sexually transmitted infections in the LGTBI+ population and the need for a person-centered approach.\n\n  \nDate: Wednesday\, March 26\, 2025\, at 7:00 p.m. \nPlace: La Vegatería (C/ Gütenberg\, 13\, 37007 Salamanca) \nIBSAL Researchers: Moncef Belhassen and Virginia Velasco \nFree admission \n  \n \n  \n\nChemSex: an emerging phenomenon or an old acquaintance? – Study of ChemSex and its impact on health from a community perspective.\n\n  \nMore information coming soon. \n  \n\nLifestyles in queer people – Promotion of healthy habits and analysis of health determinants in the LGTBI+ population.\n\n  \nMore information coming soon. \n  \n\nMental health: how to take better care of ourselves – Minority stress\, discrimination and other barriers that affect the mental health of minorities.\n\n  \nMore information coming soon. \n  \nEach workshop will combine the presentation of specialists in the field with the participation of IBSAL research staff\, bringing scientific research closer to the community. \nThe project has the collaboration of several local entities and is supported by the University of Salamanca\, the City Council of Salamanca and the IBSAL. URL:https://ibsal.es/en/evento/diverse-and-responsible-health/ LOCATION:La Vegatería\, 13 Gütenberg Street\, Salamanca\, Salamanca\, 37007\, Spain CATEGORIES:Disclosure ATTACH;FMTTYPE=image/png:https://ibsal.es/wp-content/uploads/2025/03/Logo-Iguales-Tagline-Color.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251124T061504Z CREATED:20251124T061504Z LAST-MODIFIED:20251124T061504Z UID:10002268-1767225600-1830383999@ibsal.es SUMMARY:PARTNERSHIP: European Partnership on One Health and Antimicrobial Resistance (OH AMR) DESCRIPTION:Features\nThe first joint transnational call for proposals from the EUP OHAMR Partnership on Antimicrobial Resistance\, titled “Treatments and Adherence to Treatment Protocols” \nThe goal of this call for proposals is to improve treatment success rates in patients\, animals\, and plants affected by bacterial or fungal infections by offering new treatment options while reducing the risk of resistance development across the various settings of the “One Health” approach . \nThe call for proposals is co-financed by the European Union and involves 37 funding organizations from 28 countries\, with a total estimated budget of more than 31 million euros. \nIn addition\, the following national and regional funding agencies are participating in this call for proposals: the Aragon Institute of Health Sciences (IACS)\, the State Research Agency (AEI)\, and the Carlos III Health Institute (ISCIII). \nRequirements\nProposals must address one of the following topics: \nTopic 1: Identify and develop new combination therapies using existing or innovative antimicrobials\, or antimicrobials in combination with adjunctive therapies\, to extend drug efficacy and combat resistance. \nTopic 2: Develop tools and methods to improve adherence to treatment protocols. \nTopic 3: Assess the impact of antimicrobials used in veterinary and agricultural settings on the risk of AMR transmission to humans and the environment\, to inform policies on restricting certain antimicrobials for human use. \n\nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 18\, 2025\n\n\nDeadline for Pre-Proposals\nFebruary 2\, 2026\, (1:00 p.m. CET)\n\n\nNotification of the Results of the Pre-Proposal\nApril 29\, 2026\n\n\nDeadline for full proposals\nJune 17\, 2026\, (1:00 p.m. CET)\n\n\nFinal Funding Recommendation Announced\nOctober 30\, 2026\n\n\nProjects begin\nDecember 2026–April 2027\n\n\n\n  \n  URL:https://ibsal.es/en/evento/partnership-european-partnership-on-one-health-and-antimicrobial-resistance-oh-amr-2/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251124T120728Z CREATED:20251124T120728Z LAST-MODIFIED:20251124T120728Z UID:10002252-1767225600-1830383999@ibsal.es SUMMARY:ERA4HEALTH Partnership DESCRIPTION:Features\nThe ERA4HEALTH partnership has published a joint transnational call \, “Prevent-OO: Understanding and Preventing Overweight and Obesity” Mechanisms of their onset and progression\, neglected determinants\, and novel strategies for critical transitional periods in life. \nThe call for proposals seeks to identify and implement innovative and holistic preventive and public health strategies to address obesity\, taking into account environmental\, psychological\, and socioeconomic factors to promote healthier lifestyles. In addition\, ERA4Health fosters transnational and interdisciplinary collaborations with a translational approach to generate new knowledge and develop effective prevention strategies. \nThe call for proposals is co-financed by the European Union and involves 25 funding organizations from 20 countries\, with a total estimated budget of more than 18 million euros. \nIn addition\, the Carlos III Health Institute (ISCIII) is participating in this call for proposals as the national funding agency. \nRequirements\nApplications must cover only one of the two topics listed below and address at least one of the two specified subtopics (subtopic 1a and/or 1b for topic 1\, and subtopic 2a and/or 2b for topic 2); both topics and subtopics are equally relevant for this call: \n1. Understanding the causes of obesity and overweight and their complications through mechanistic research \n1a. To investigate biological mechanisms—including chronobiological\, genetic\, and/or epigenetic mechanisms—underlying the onset and progression of overweight and obesity\, as well as related diseases. Secondary factors that may influence these biological mechanisms—such as the living environment\, lifestyle\, or psychological status—should also be considered where relevant. \n1b. To investigate how being overweight and obesity contribute to the development of related clinical complications and/or affect the mechanism of action of treatments for other diseases or disorders. \n2. Prevention and public health strategies for critical transitional periods of life. Both subtopics 2a. and 2b. should address critical transitional periods of life only. The choice of the critical transitional periods of life to be studied must be clearly justified in the proposal. These periods should result from biological changes (e.g.\, postpartum\, menopause\, andropause) or socio-environmental changes (e.g.\, the period between pregnancies\, diagnosis of a chronic disease\, recovery from illness\, retirement\, etc.). \n2a. To understand and address neglected determinants—including their interdependence—in the onset and progression of overweight and obesity during transitional periods of life. \n2b. To develop novel tools or preventive strategies that can be implemented to prevent the onset and progression of overweight and obesity during transitional periods of life\, taking into account physiological\, pathophysiological\, psychological\, and behavioral influences and/or the socioeconomic status of citizens/patients. Importantly\, the proposal should include an assessment of the economic impact of the proposed tools or strategies on the healthcare system and provide recommendations to help policymakers define new regulations and guidelines to prevent overweight and obesity. \n\nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 13\, 2025\n\n\nDeadline for Pre-Proposals\nJanuary 21\, 2026\, (12:00 CET)\n\n\nNotification of the Results of the Pre-Proposal\nApril 13\, 2026\n\n\nDeadline for full proposals\nJune 11\, 2026\, (12:00 CET)\n\n\nRebuttal Phase\nAugust 24\, 2026\n\n\nProjects begin\nDecember 2026–May 2027\n\n\n\n  \n  URL:https://ibsal.es/en/evento/era4health-partnership-2/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251126T071112Z CREATED:20251126T071112Z LAST-MODIFIED:20251126T071112Z UID:10002178-1767225600-1830383999@ibsal.es SUMMARY:PARTNERSHIP European Partnership for Personalized Medicine (EP PerMed) DESCRIPTION:Features\nA joint transnational call for proposals has been published by the European Partnership for Personalized Medicine (EP PerMed)\, Joint Transnational Call (JTC) 2026: Personalized Medicine for Cardiovascular\, Metabolic\, and Kidney Diseases (CARMEN2026) \nThis call for proposals will fund human health research projects on innovative personalized medicine strategies for patients with cardiovascular\, metabolic\, or kidney diseases. Research projects may focus on a single disease or address these conditions in combination. \nResearch projects that combine a personalized medicine approach with care strategies targeting shared biological pathways or common underlying mechanisms of cardiovascular\, metabolic\, and renal diseases will be viewed favorably. \nThe call for proposals is co-funded by the European Union and involves 39 funding organizations from 27 countries\, with a total estimated budget of over 38 million euros. \nIn addition\, the Carlos III Health Institute (ISCIII) is participating in this call for proposals as the national funding agency. \nRequirements\nProposals should address one or more of the following aspects: \n\nDevelopment and validation of innovative\, personalized therapeutic approaches for cardiovascular\, metabolic\, or kidney diseases through testing in relevant preclinical models (e.g.\, human cell cultures\, organoids\, organs-on-chips\, disease-specific animal models\, or in silico models).\nIdentification and validation of molecular markers/signatures or cutting-edge technologies (see also point 2 below) to monitor treatment response in patients with cardiovascular\, metabolic\, or kidney diseases in order to tailor treatment pathways. This may include the analysis of treatment effectiveness or treatment-related (including those associated with multiple medications) adverse effects\, as well as dose optimization. \nIdentification and validation of stratifying molecular markers or signatures\, or stratifying diagnostic technologies\, for the early prediction of disease risk and the prevention of disease progression or comorbidities in patients with cardiovascular\, metabolic\, or kidney diseases\, thereby delaying the progression to cardiovascular-kidney-metabolic syndrome.\n\n  \nResearch projects that combine a personalized medicine approach with care strategies targeting shared biological pathways or common underlying mechanisms of cardiovascular\, metabolic\, and kidney diseases are welcome. \nProjects funded under this call are also required to include a dedicated work package focusing on the translation or implementation of research outcomes into clinical practice\, with an emphasis on\, for example\, patient outcomes\, patient preferences\, costs\, reimbursement\, education (for healthcare providers\, patients\, and citizens)\, ELSA (ethical\, legal\, and societal aspects)\, or accessibility at the point of care. \nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 25\, 2025\n\n\nDeadline for Pre-Proposals\nFebruary 10\, 2026\, (2:00 p.m. CET)\n\n\nNotification of the Results of the Pre-Proposal\nMay 5\, 2026\n\n\nDeadline for full proposals\nJune 9\, 2026\, (2:00 p.m. CET)\n\n\nRebuttal stage\nMid- to late August 2026\n\n\nNotification of Funding Decisions\nOctober 2026\n\n\n\n  \n  URL:https://ibsal.es/en/evento/partnership-european-partnership-for-personalized-medicine-ep-permed/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20280102 DTSTAMP:20251215T081017Z CREATED:20251215T081017Z LAST-MODIFIED:20251215T081017Z UID:10002206-1767225600-1830383999@ibsal.es SUMMARY:PARTNERSHIP: Transforming Health and Care Systems (THCS) DESCRIPTION:Features\nA joint transnational call for proposals has been published by the Transforming Health and Care Systems (THCS) partnership\, Joint Transnational Call for Proposals (2026) on Access to Care. \nThis call for proposals promotes the coordination and optimization of research and innovation efforts to support the necessary transformation of health and social care systems in Europe and partner countries. Its goal is to fund projects that help ensure equitable access to and appropriate use of health and care services\, providing policymakers and decision-makers with the knowledge and tools needed to reallocate resources effectively. \nThe projects\, based on existing evidence\, will develop innovative solutions to reduce inequalities in access to care by addressing financial models\, service delivery models\, and integrated and interdisciplinary care programs at all levels of the system. \nThe call for proposals is co-financed by the European Union and involves 32 funding organizations\, with a total estimated budget of more than 35 million euros. \nIn addition\, the Carlos III Health Institute (ISCIII) is participating in this call for proposals as the national funding agency. \nRequirements\nThe aim of the call is to fund research and innovation projects that\, within an ecosystem approach\, contribute to ensuring equitable access to and use of health and care services. Through the funded research and innovation projects\, policymakers and decision-makers should gain the knowledge and tools necessary to implement the reallocation of resources as the health and care system undergoes a transition to address new and ongoing challenges. \nAll proposals would benefit from co-creation with stakeholders\, particularly people from disadvantaged groups. Proposals are encouraged to incorporate elements of the social sciences as part of an interdisciplinary approach. \nThis call requires collaborative\, transnational research\, innovation\, and evaluation activities. It is mandatory to engage in one or more of the following types of activities: applied research\, implementation research\, piloting\, upscaling\, and/or testing. All projects must demonstrate proof of concept(s)\, validate concepts\, models\, or solutions\, and showcase demonstrations of solutions in relevant health and care ecosystems. The adaptation of already adopted solutions to other settings is also within the scope of this call. \n  \nSubmission deadline.\nThe following table lists the different dates: \n\n\n\nPhase\nDate\n\n\n\n\nCall Opens\nNovember 21\, 2025\n\n\nDeadline for Pre-Proposals\nFebruary 2\, 2026\, (2:00 p.m. CET)\n\n\nCall for Full Proposals\nStarting May 11\, 2026\n\n\nDeadline for full proposals\nJune 30\, 2026\, (2:00 p.m. CET)\n\n\nRebuttal stage\nSeptember 2026\n\n\nNotification of Funding Decisions\nLate October 2026\n\n\n\n  \n  URL:https://ibsal.es/en/evento/partnership-transforming-health-and-care-systems-thcs/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260101 DTEND;VALUE=DATE:20270101 DTSTAMP:20260112T060813Z CREATED:20260112T060813Z LAST-MODIFIED:20260112T060813Z UID:10002251-1767225600-1798761599@ibsal.es SUMMARY:Reticular Model of Organization and Community Care for People with Mental Illness DESCRIPTION:Coeducational Course: “Reticular Model of Organization and Community Care for People with Mental Illness“ \n  \nObjective: \nTo explain how the network-based model for organizing mental health services and facilities works\, with a focus on the coordination of social and health care services and between mental health and primary care. \n  \nSpecific objectives: \n\nBecome familiar with all the health and social care services integrated into the mental health social-health care network under the network model. Describe the operations and objectives of the Assertive Community Treatment Unit. Conduct a study to develop a feasible proposal for implementation in your workplace.\nTo understand the changes introduced by the model to improve the quality of care in the field of mental health. \nIdentify the epistemological and organizational foundations of the model and its implementation in a healthcare region such as Zamora. \nTo lay the groundwork for coordination among distinct care networks—such as social-health\, social\, and health care networks—as well as to define the new roles of workers within these networks.\n\nDate: \nFrom August 1 to December 31\, 2025. \n  \nLocation: \nOnline and the Zamora Mental Health Department. \n  \nEnrollment: \n  \nRegistration is open throughout the academic year on an individual basis via our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \n  \nPrice: \n50 euros (USAL students\, PhD students\, IBSAL members\, students from developing countries\, primarily in Latin America). \n150 euros (general admission). \n  \nMethod of selection: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  URL:https://ibsal.es/en/evento/reticular-model-of-organization-and-community-care-for-people-with-mental-illness/ LOCATION:Online CATEGORIES:Course END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260210 DTEND;VALUE=DATE:20260916 DTSTAMP:20260225T064245Z CREATED:20260225T064245Z LAST-MODIFIED:20260225T064245Z UID:10002238-1770681600-1789516799@ibsal.es SUMMARY:Horizon Europe. Cancer Mission 2026 and 2027 DESCRIPTION:Features\nThe work program for the Cancer Missions under Horizon Europe for 2026 and 2027. \nThese are single-phase calls for proposals\, aimed at international multidisciplinary consortia\, which must submit a proposal in accordance with the specifications for each topic. \nAdmission requirements\, eligibility criteria\, and the necessary documents are described in the General Annexes. \n  \nThese are the topics included in the Cancer Mission’s new Work Program for the year 2026: \nThese topics are single-phase: they begin on February 10\, 2026\, and end on September 15\, 2026. \nHORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research \nHORIZON-MISS-2026-02-CANCER-02: Microbiome for Early Cancer Prediction Before the Onset of Disease \n\nHORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimize immunotherapy interventions for patients with refractory cancers \nHORIZON-MISS-2026-02-CANCER-04: Earlier and More Precise Palliative Care \nHORIZON-MISS-2026-02-CANCER-05: Improving the mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) \nHORIZON-MISS-2026-02-CANCER-06: Development of a research capacity-building program on cancer with and for Ukraine (csa) \nHORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of Older Cancer Patients \n\nA very interesting topic in the “Soil Deal for Europe” section\, which opens on February 4\, 2026\, and closes on September 23\, 2026: \nHORIZON-MISS-2026-05-SOIL-02: Antimicrobial Resistance and Antibiotic Biosynthesis in Soils: Developing Key Insights and Countermeasures Using a One-Health Approach \n  \nThese are the topics included in the Cancer Mission’s new Work Program for the year 2027: \nThese topics are single-phase: they begin on February 10\, 2027\, and end on September 21\, 2027. \nHORIZON-MISS-2027-02-CANCER-01: Leveraging functional genomics to identify novel targets for cancer treatment \nHORIZON-MISS-2027-02-CANCER-02: Clinical research conducted by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers \nHORIZON-MISS-2027-02-CANCER-03: Phase 1\, including first-in-human clinical trials to test biomarker-guided medicines or multimodal treatment interventions for patients with rare or very rare cancers or cancer subtypes \nHORIZON-MISS-2027-02-CANCER-04: Improving equitable health outcomes and added value for and with cancer patients through health economics research\, health systems research\, and outcomes research \nHORIZON-MISS-2027-02-CANCER-05: Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies\, cancer medical devices\, or cancer medicines \nHORIZON-MISS-2027-02-CANCER-06: Support for a research program on the quality of life (QoL) of young cancer survivors\, led by cancer charities and funding agencies (csa) \nThis is a very interesting topic—a Joint Call for Missions. The call opens on February 4\, 2027\, and closes on September 21\, 2027: \nHORIZON-MISS-2027-06-SOIL-CANCER: Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks \n  \n**If you’re interested in any of our job openings or need more information\, please don’t hesitate to contact us. \n\n\n\nRequirements:\nThese calls for proposals are aimed at multidisciplinary European consortia. Unless otherwise specified in the specific conditions of the call\, only legal entities that form a consortium will be eligible to participate in the actions\, provided that the consortium includes\, as beneficiaries\, three legal entities that are independent of one another\, each established in a different country\, in accordance with the following criteria: \n\n\nat least one independent legal entity established in a Member State; and \n\n\nat least two other independent legal entities\, each established in different Member States or Associated Countries. \n\n\nLegal entities established in Russia\, Belarus\, or in territories of Ukraine not controlled by the government are not eligible. \nHow to apply\nApplications consist of two sections: \n-Part A (to be completed online) contains administrative information related to the consortium\, the budget\, and specific details of the call for proposals. \n-Part B (a template downloaded from the Commission’s website must be completed) contains the scientific and technical aspects of the project. \n  \nSubmission deadline.\nThe 2026 application deadlines are September 15\, and the process is a single-stage process\, With the exception of call HORIZON-MISS-2026-05-SOIL-02\, which ends on September 23\, 2026. \nThe application deadlines for 2027 are September 21\, 2027\, and the application process consists of a single stage. URL:https://ibsal.es/en/evento/horizon-europe-cancer-mission-2026-and-2027/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260226 DTEND;VALUE=DATE:20261029 DTSTAMP:20260804T112434Z CREATED:20260601T085642Z LAST-MODIFIED:20260804T112434Z UID:10002348-1772064000-1793231999@ibsal.es SUMMARY:European Innovation Council (EIC) Pathfinder Challenges DESCRIPTION:Features\nThe Commission’s EIC Pathfinder program supports early-stage\, disruptive technological innovations with revolutionary potential. \nFrom the conception of an idea to proof of concept (TRL 1–4)\, the EIC Pathfinder\, as part of the EIC’s Horizon Europe work program\, funds innovative technologies with a transformative impact. It offers two funding options: Open and Challenges\, the latter of which is aimed at specific objectives defined by the EIC and is currently open for applications. \nRequirements:\nThe budget is 96 million euros\, and the topics are: specific challenges of EIC Pathfinder. \nThe following is a list of topics with links: \n\nPathfinder Challenge 1: Advanced Materials for Miniaturized Energy Harvesting Systems: to support the next generation of energy-autonomous systems and IoT devices. Advanced Materials for Miniaturized Energy Harvesting Systems. \nPathfinder Challenge 2: Biotechnology for Healthy Aging: Develop biotechnological or pharmaceutical interventions to prevent\, delay\, or reverse age-related diseases. Biotechnology for Healthy Aging\nPathfinder Challenge 3: DeepRAP: Deep Reasoning\, Abstraction\, and Planning for Trustworthy Cognitive AI Systems: Promoting trustworthy cognitive AI through deep reasoning\, abstraction\, and planning. DeepRAP: Deep Reasoning\, Abstraction & Planning towards trustworthy Cognitive AI Systems\n\n  \nThey are European consortia consisting of at least two entities from different countries or a single legal entity established in a Member State or an associated country. \nEligible applicants include: research organizations and universities\, as well as startups and small and medium-sized enterprises (SMEs) developing high-risk\, high-impact technologies. \nMid- and large-cap companies may not apply as lead applicants. \n  \nProposals are scored (0–5) based on three criteria: \n\nExcellence: ambition\, innovation\, and a high-risk/high-return vision.\nImpact: potential to lay new foundations for innovative technologies.\nImplementation: quality of the consortium and the work plan.\n\n  \nTie-breaking criteria: higher scores for excellence and impact\, gender balance\, and participation by SMEs and countries with the highest participation rates. \nAll essential research-related expenses\, including those for personnel\, equipment\, travel\, and subcontracting\, are covered under the lump-sum grant. \nSubmission Deadline\nThe deadline is October 28\, 2026. URL:https://ibsal.es/en/evento/european-innovation-council-eic-pathfinder-challenges/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260331 DTEND;VALUE=DATE:20260926 DTSTAMP:20260518T065918Z CREATED:20260518T065918Z LAST-MODIFIED:20260518T065918Z UID:10002263-1774915200-1790380799@ibsal.es SUMMARY:CDTI Eureka Biotech Call 2026 DESCRIPTION:Features\nThe CDTI and the Eureka program are launching their international call for proposals\, the Eureka Biotech Call 2026\, an initiative aimed at promoting international collaborative R&D projects focused on developing innovative solutions in the field of biotechnology. \n\nSeventeen countries and regions are participating in the call for proposals: Austria\, Belgium (Flanders and Wallonia)\, Canada\, Chile\, Estonia\, France\, Germany\, Lithuania\, the Netherlands\, Singapore\, South Africa\, South Korea\, Spain\, Sweden\, Switzerland\, and Turkey. \n\nThis call for proposals represents an excellent opportunity to promote international collaborative projects with a clear market focus and high potential for industrial implementation in the biotechnology sector. Proposals may address a wide range of research and innovation areas related to: \n\nAdvanced Biomanufacturing and Enabling Technologies for Biotechnology Ecosystems\nNext-Generation Therapies and Treatments\nAgricultural and Veterinary Innovations\nAdvanced Diagnostics and Data-Driven Technologies\nBioinformatics\, Artificial Intelligence\, and Digitalization Applied to Biotechnology\nBioprocess Technologies and Sustainable Bioindustrial Solutions\n\n  \nApplication areas include\, among others: \n\nHealth and Medicine\nPharmaceuticals and Advanced Therapies\nIndustrial Biotechnology\nAgriculture and Food\nDiagnostics and Medical Devices\nBioeconomy and Sustainability\nDigital Health and Biological Data Analysis\n\n  \nThe call for proposals will feature activities and international networking tools to facilitate the identification of partners and the formation of collaborative consortia among companies\, startups\, universities\, and technology centers interested in developing joint projects. \nRequirements:\nThis call for proposals is aimed at market-oriented R&D projects involving experimental development activities and with technology readiness levels primarily ranging from TRL 5 to TRL 7. The participation of at least two independent entities from two different participating countries will be required\, with companies playing a significant role within the international consortia. \nThe minimum budget for each company is €175\,000. There is no budget limit for Spanish partners\, but the budget must be commensurate with the activities to be carried out and the company’s capacity. \nThe Spanish company (or the Spanish consortium coordinator\, where applicable) must submit a formal application for funding for the international R&D project through the CDTI’s online portal by October 2\, 2026. The application must include the Eureka Application Form (in English) and\, when available\, a draft of the consortium agreement. The signed consortium agreement must be submitted before the Eureka label is granted. \nOnce the international application has been received\, CDTI will verify the eligibility of the Spanish applicants. If they are deemed eligible\, CDTI will process the corresponding national funding applications for each Spanish participant. These applications must be completed and duly submitted by all Spanish partners within the deadline set by CDTI\, approximately one month after the call’s deadline. \nDepending on the funding instrument requested\, CDTI may require the submission of additional documentation in Spanish. Spanish partners who do not submit the required applications by the established deadlines may be excluded. \nFunding for startups\, SMEs\, and large companies covers up to 85% of the project’s eligible costs. \nIBSAL (a research center) and universities are participating as subcontractors in the project. \nHow to apply\nThe deadline for submitting applications is September 25\, 2026\, at 11:59 p.m. CEST. \nProject start date: second quarter of 2027 \nYou can find all the information about the objectives\, eligibility requirements\, application process\, and funding for this call at the following link: Eureka Biotech Call 2026. \n  URL:https://ibsal.es/en/evento/cdti-eureka-biotech-call-2026/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260409 DTEND;VALUE=DATE:20260901 DTSTAMP:20260528T100357Z CREATED:20260528T100357Z LAST-MODIFIED:20260528T100357Z UID:10002318-1775692800-1788220799@ibsal.es SUMMARY:Horizon Europe. Marie Sklodowska-Curie: Postdoctoral Fellowships - Global Fellowships 2026 DESCRIPTION:Features\nThe goal of the postdoctoral fellowships under the European Marie Sklodowska-Curie Actions (MSCA) program is to enhance the creative and innovative potential of young PhD graduates who wish to acquire new skills through advanced training and international\, cross-sectoral\, and interdisciplinary mobility. \nThe program also encourages researchers to work on research and innovation projects in the non-academic sector and is open to those who wish to return to Europe\, those displaced by conflict\, and high-potential researchers seeking to resume their research careers. \nGrants are awarded to outstanding researchers undertaking international mobility\, whether to or between EU Member States or countries associated with Horizon Europe\, as well as to non-associated third countries. Applications must be submitted jointly by the researcher and a beneficiary organization from either the academic or non-academic sector. \nThere are two categories:“European Fellowships” and“Global Fellowships.” \nThe“MSCA Global Fellowships” program is aimed at researchers who are European nationals or long-term residents of the European Union and who wish to participate in R&D&I projects with organizations located outside the EU Member States and the countries associated with Horizon Europe. \nThese grants require an outbound phase lasting a minimum of 12 months and a maximum of 24 months in a non-associated third country\, followed by a mandatory 12-month return phase with a host organization located in an EU Member State or a country associated with Horizon Europe. \nSecondments may be undertaken within the total duration of the grant in any country in the world. This secondment phase may take place as a single period or be divided into several shorter periods of mobility. \nIn the case of Global Postdoctoral Fellowships\, optional stays of up to one-third of the outbound phase are permitted. A maximum of three months of these stays may take place at the start of the project at the beneficiary organization (or at partner organizations affiliated with the beneficiary). This maximum period of three months will be considered part of the outbound phase. Stays are not permitted during the mandatory 12-month return period to the host organization in an EU Member State or a country associated with Horizon Europe. \nIn addition to these placements\, placements in the non-academic sector may be considered. A placement of up to six months in a business sector institution may be undertaken\, always at the end of the grant period\, and provided that this placement was included in the application phase. \nThe call for proposals has a budget of 59.86 million euros for this type of grant. \n\n\n\nRequirements:\nRequirements for participating entities:\n\n\nThe host institution\, which enters into the employment contract with the researcher for the duration of the project\, must be located in a Member State of the European Union or an Associated Country.\nA partner from a third country that hosts the candidate during the first phase of the grant (“outgoing phase”) must include a letter of commitment in the proposal to ensure its active participation in the action.\n\n\nCandidate Requirements:\n\n\nApplicants must be postdoctoral researchers; that is\, they must hold a doctoral degree by the application deadline. Candidates who have defended their doctoral dissertation but have not yet formally received their doctoral degree will also be considered postdoctoral researchers and will be eligible to apply. \nAs of the application deadline\, candidates must have a maximum of 8 years of full-time postdoctoral research experience (counted from the date the Ph.D. degree was awarded). Years of experience outside of research and career breaks (e.g.\, maternity or paternity leave) will not count toward the years of research experience. For nationals or long-term residents of EU Member States or countries associated with Horizon Europe who wish to return to pursue their research careers in EU Member States or associated countries\, years of research experience in third countries will not be considered in the above calculation. \nComply with the mobility rule: not having resided in or carried out their main activity (work\, studies\, etc.) in the country of the applying or host institution during the first phase (“outgoing phase”) for more than 12 months in the 36 months immediately preceding the call deadline. Researchers who wish to return from a third country to a European or associated country must be based in the third country as of the application deadline or must have moved directly from a third country to a Member State or associated country within the 12 months prior to the call deadline. \nApplicants must be nationals or long-term residents of an EU member state or a country associated with Horizon Europe. Researchers who are not EU nationals but have resided in an EU country under a research contract for 5 consecutive years are considered long-term residents. \n\nResubmission: Researchers who participated in the 2025 MSCA-PF call and received a score below 80% may not resubmit the same proposal through the same institution. \n\nHow to apply\nProposals are submitted electronically through the Funding and Tender Portal ( select “Start submission”). To use the proposal preparation and submission service\, you must have an EU Login / ECAS account. \nApplications consist of two sections: \n-Part A (to be completed online) contains administrative information related to the applicant entity or entities and specific details regarding the call for proposals. \n-Part B (a template is filled out\, which can be downloaded from the Commission’s portal once we begin the application;the “Standard Application Form (HE MSCA PF) ” contains the scientific and technical portion of the project.) \n  \nSubmission deadline.\nThe deadline set by the Commission is August 31\, 2026\, at 5:00 p.m. URL:https://ibsal.es/en/evento/horizon-europe-marie-sklodowska-curie-postdoctoral-fellowships-global-fellowships-2026/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260421 DTEND;VALUE=DATE:20270116 DTSTAMP:20260518T124654Z CREATED:20260518T124654Z LAST-MODIFIED:20260518T124654Z UID:10002294-1776729600-1800057599@ibsal.es SUMMARY:Call for Applications: INVESMIR SEC-CNIC Training Program 2026 DESCRIPTION:Purpose\nThe INVESMIR SEC-CNIC Program aims to supplement the training of medical professionals during their hospital residency by facilitating the development of a research project in the CNIC laboratories under the supervision of a CNIC scientist. \nThis program also aims to establish the necessary connections and partnerships so that\, upon completing their specialization\, these professionals can continue to develop their research projects at their respective hospitals\, with the support of the SEC and the CNIC. \n  \nTerms and Conditions\nA maximum of 10 spots will be awarded for the INVESMIR SEC-CNIC training program in the 2026 call for applications. \nThe potential recipient groups for the CNIC under this program and information regarding their research areas are available at the following link:\nhttps://www.cnic.es/es/investigacion/laboratorios \nInterested individuals must contact the research groups and be accepted into one of them in order to apply.\nIn all cases\, the training stints will be full-time. \nParticipants from hospitals outside the Community of Madrid will have their travel expenses to Madrid covered up to a maximum of 300 € (one round-trip from their usual place of residence; if traveling by public transportation\, it must be in economy class\, in accordance with the CNIC’s travel policy). In addition\, these participants will be reimbursed for accommodation expenses in Madrid up to a maximum of 250 euros per week. Any amounts exceeding the weekly limit will be offset against one another\, provided they do not exceed 1\,000.00 € over a four-week period. \nAll expenses must be supported by documentation\, including invoices issued in the participant’s name and proof of payments made from their bank account. The documentation must be sent in a single email to programa_formación@cnic.es within 10 calendar days after the end of the stay at the Center. Once the documentation has been reviewed\, the participant will be notified of which supporting documents must be submitted as original hard copies (invoices\, receipts\, or other supporting documents) and mailed to the Center’s address. \nParticipation in the internship will not entail any type of contractual relationship between the intern and the CNIC. \n  \nDuration and Length of Stay\nThe duration of the stay will be flexible\, ranging from 4 to 6 months\, in accordance with the regulations set forth in the MIR Training Program of the participant’s home hospital.\nStays must take place entirely between June 1\, 2026\, and May 31\, 2027\, except in exceptional circumstances duly authorized by the CNIC and SEC management. \n  \nRequirements\nBe a member of the Spanish Society of Cardiology (SEC).\nBe a medical professional\, of any nationality\, currently in the R3\, R4\, or R5 years of a residency program in Cardiology or Cardiovascular Surgery at a hospital in Spain. \n  \nDeadline and Formalization\nThe call for applications will be open from April 21\, 2026\, through January 15\, 2027.\nApplications must be submitted exclusively through the CNIC online system:\nhttps://www.cnic.es/es/convocatoria/invesmir-sec-cnic\, and the following documentation must be attached: \n\nResume.\nNational Identity Card.\nDocument verifying your personal Social Security number (those issued by mutual insurance companies are not valid).\nA signed authorization from the Academic Committee of the training program at the participant’s home hospital\, expressly stating the dates of the stay.\nLetter of Acceptance from the CNIC Supervising Researcher Responsible for the Stay\nBrief description of the proposed research project for the residency\nCertificate of residence for candidates residing in Spain outside the Community of Madrid.\n\nDocuments must be attached to the form in PDF format. \nFollowing the publication of the call for applications\, applications will be reviewed on the 15th of each month. Each applicant will then be notified by email whether their application has been accepted or\, if applicable\, the reasons for requiring corrections or for exclusion. Applicants in the correction phase may correct the errors that led to the rejection of their application within a maximum period of 5 days\, starting the day after the notification date. The decision regarding admission to or exclusion from the evaluation process will be communicated through the same procedure. \nElectronic signatures will be used throughout the selection process and the subsequent hiring procedures; therefore\, applicants must have a digital ID (DNIe) or a recognized electronic certificate issued by a registered certification authority (https://sedeaplicaciones.minetur.gob.es/Prestadores/)\, such as the one issued by the National Mint and Stamp Factory. \nTERMS AND CONDITIONS OF THE CALL FOR APPLICATIONS URL:https://ibsal.es/en/evento/call-for-applications-invesmir-sec-cnic-training-program-2026/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260501 DTEND;VALUE=DATE:20270101 DTSTAMP:20260518T094535Z CREATED:20260518T094535Z LAST-MODIFIED:20260518T094535Z UID:10002280-1777593600-1798761599@ibsal.es SUMMARY:EATRIS-CONNECCT Knowledge Exchange Program DESCRIPTION:Features\nThe call for applications for the EATRIS-CONNECT knowledge exchange program offers grants of up to €1\,000 for researchers who wish to spend time at an eligible research institution\, with a focus on improving digital transformation in translational medicine. The program covers travel\, lodging\, and living expenses related to the visit. \nDigital transformation in translational medicine refers to the use of advanced digital technologies—such as data\, tools\, and services—to develop innovative solutions to unmet medical needs. \nThe call for applications is open to both EATRIS-CONNECT project partners and EATRIS organizations that are not officially part of the consortium. Expenses will be reimbursed upon completion of the visit and submission of the final report. \nRequirements\nWhat types of exchanges are funded? \nThere are no predefined exchange types\, but some examples include: \n\nDigital Transformation Literacy (DT Literacy): Individual staff exchanges between nodes to facilitate the transfer of knowledge related to digital solutions\, workflows\, and service delivery that support the development of translational medicine.\nWorkshops: group exchange of best practices or collaborative development of digital solutions.\nCollaborative initiatives: sharing experiences and ideas to drive joint digital transformation initiatives.\nOnline or virtual knowledge-sharing sessions: digital seminars\, webinars\, and other virtual events for sharing knowledge.\n\n\n\n\nHow to apply\nYou must submit the “Knowledge Exchange proposal” via this link to the application form. Before submitting it\, please verify your eligibility\, and we recommend that you read the program guide. \nThere is no deadline for submitting applications. URL:https://ibsal.es/en/evento/eatris-connecct-knowledge-exchange-program/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260505 DTEND;VALUE=DATE:20261001 DTSTAMP:20260512T063852Z CREATED:20260512T063852Z LAST-MODIFIED:20260512T063852Z UID:10002269-1777939200-1790812799@ibsal.es SUMMARY:36th Annual Mutual Médica Scholarship - Mutual Médica Foundation DESCRIPTION:Purpose\nThe Mutual Médica Foundation\, through its Impulsar(me) program\, is announcing a new call for applications for the Mutual Médica Research Grant\, intended for resident physicians who are in their final year or who have completed their residency within the last three years. The research must have potential applications in clinical practice. \nThe purpose of the scholarship is to support young researchers\, where “support” means helping young professionals bring to fruition research projects with the potential to bring about change\, especially at the most challenging time: at the beginning of their medical careers. \n  \nAmount\nThrough this scholarship\, the Mutual Médica Foundation supports physicians who are in their final year of the MIR program or who have completed their residency within the last three years. The winning research project will receive a grant of 25\,000 €\, and two runner-up prizes of 5\,000 € each will be awarded. \n  \nRequirements\nThe candidate must be a physician and be a member of one of the Official Medical Associations in Spain.\n— At the time of applying for the scholarship\, the candidate must be in their final year of residency\, or must have completed it this year or in one of the three preceding years\, from 2023 to 2025.\n— The research proposal must include the title of the project\, the name of the fellow\, the primary and secondary objectives\, the research hypothesis\, the materials and methodology to be used\, as well as the relevance and potential clinical implications of the research.\n— The work must be completed within a maximum of two years from the date the first grant is awarded.\n— Members of the Board of Directors of Mutual Médica and the Board of Trustees of the Mutual Médica Foundation\, as well as their family members\, are not eligible for the scholarship. \n  \nDocumentation\nTo be eligible for the grant\, the research physician must submit the following documentation:\n• Application form: Please fill out the form available at www.fundacionmutualmedica.com\n• Copy of ID card.\n• A certificate from the Director of Labor attesting to the candidate’s qualifications\, stating the Director’s commitment to monitor the candidate’s progress\, and verifying that the work can be completed within a period of 2 years.\n• A certificate from the director of the center or institution where the research is to be conducted\, confirming acceptance of the proposed work and stating that the technical capabilities necessary for its completion are available.\n• A document from the Clinical Research Ethics Committee of the relevant accrediting institution stating its approval\, if the study involves the participation of patients.\n• Resume.\n• Research Project. \nSubmission of documentation: \nAll documentation can be submitted as scanned copies:\n• Through the online form available at\nwww.fundacionmutualmedica.com (recommended option)\n• By email to premiosinvestigacion@fundacionmutualmedica.com\n• By certified mail to the secretariat of the Fundación Mutual Médica (Via Laietana\, 31\, 08003 Barcelona).\n• The deadline for submitting documentation is September 30\, 2026.\n• Copies of the duly signed originals of the Director of Labor’s Certificate\, the Center Director’s Certificate\, and the Ethics Committee Document must be provided. \n  \nComplete guidelines for the call for applications\nScholarship Application \n  URL:https://ibsal.es/en/evento/36th-annual-mutual-medica-scholarship-mutual-medica-foundation/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260514 DTEND;VALUE=DATE:20260916 DTSTAMP:20260515T121513Z CREATED:20260515T121513Z LAST-MODIFIED:20260515T121513Z UID:10002304-1778716800-1789516799@ibsal.es SUMMARY:Call for Entries: 3rd Aurelio Palomo Research Awards - Aless Lequio Foundation DESCRIPTION:Objective\nThe Aless Lequio Foundation invites research groups\, clinical trial teams\, and healthcare institutions to submit proposals to receive funding to support innovative projects aimed at finding a cure for Ewing sarcoma. The purpose of this call for proposals is to promote research and the development of effective treatments for this disease\, which affects a significant number of young people. \n  \nParticipants\n– Academic research groups. \n– Healthcare institutions. \n– Clinical trial teams. \n– Nonprofit organizations working in the field of oncology. \n  \nRequirements\nProposals must include the following information in order to be considered: objectives\, experimental design or scientific plan\, type of models to be used or methodology\, costs\, and timeline. \n– Project title. \n– Project description: Project objectives\, experimental design or scientific plan\, type of models to be used or methodology\, and relevance to the search for a cure for Ewing sarcoma. \n– Research Team: Resumes of the principal investigators and collaborators. \n– Detailed budget: Breakdown of the funding required to carry out the project and a justification for it. – Timeline: Project phases and estimated completion times. – Expected results: Potential impact on the research and treatment of Ewing sarcoma. \n  \nFunding\nThe Aless Lequio Foundation will award a grant of €50\,000 to the selected project\, which will be used exclusively to carry out the proposed activities. \n  \nAssessment Criteria\nProposals will be evaluated based on the following criteria: \n– Innovation and originality of the approach. \n– Technical and scientific feasibility. \n– Experience of the research team. \n– Potential impact on the treatment of Ewing’s sarcoma. \n  \nSubmission Deadlines\nProposals must be submitted by September 15\, 2026\, to the following email address: info@fundacionalesslequio.org. \n  \nContact\nhttps://fundacionalesslequio.org/ \ninfo@fundacionalesslequio.org \nPhone: 690966291 – 637747295 \n  \n  URL:https://ibsal.es/en/evento/call-for-entries-3rd-aurelio-palomo-research-awards-aless-lequio-foundation/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20260518T120000 DTEND;TZID=Europe/Helsinki:20260911T235900 DTSTAMP:20260701T100404Z CREATED:20260701T100404Z LAST-MODIFIED:20260701T100404Z UID:10002262-1779105600-1789171140@ibsal.es SUMMARY:Call for Entries: Eva P. Bech Awards (1st edition) - Spanish Liver Federation DESCRIPTION:Objective\nThese awards were created to recognize and highlight initiatives\, achievements\, and best practices that support the rights and interests of people with liver disease and/or who have undergone a liver transplant\, as well as their families and people with organic disabilities. \nFurthermore\, these awards aim to highlight the commitment of the nonprofit sector\, the work of volunteers\, the efforts of healthcare professionals\, and the promotion of research and social activism in this field. \n  \nGeographic Scope\nThis call for proposals is open nationwide and is intended for projects with an impact at the national\, provincial\, or municipal level. \n  \nApplications\n— Submission of Nominations. Nominations must be submitted by the nominees themselves (individuals or legal entities\, as applicable to the category) in PDF format\, including the information required in each appendix corresponding to the award category for which they are applying\, and sent to the following email address: premiosevapbech@fehigado.org. Legal entities with their registered office in Spain\, as well as individuals who are at least 18 years of age\, are eligible to participate. Nominations that do not comply with this submission format will not be considered. Each nomination must include a descriptive report and may\nbe accompanied by graphic or audiovisual materials to support the merits of the nomination. \n— Submission period. The submission period will run from May 18\, 2026\, at 12:00 p.m. (Peninsular Time) and will end on September 11\, 2026\, at 11:59 p.m. (Peninsular Time). Proposals submitted after this date will not be accepted. \n— Number of nominations. Candidates who meet all the requirements set forth in these rules may submit a maximum of one nomination per category. \n— Jury. It will be composed of a diverse group of members from the FEH Executive Committee and external experts from various fields. The jury will evaluate criteria such as relevance\, social impact\, innovation\, and the transferability of the practices (their ability to be replicated in other contexts). \n— Specific restrictions by category. In Categories 1 and 5\, only organizations that are members of the FEH as of the application deadline may participate. \n  \nCategories\n1. Best project already implemented by a member association \nThis category recognizes both projects involving direct patient care and initiatives focused on innovation in internal management\, modernization\, and efficiency that have contributed to strengthening the association and were implemented during the immediately preceding year. \n2. Resident healthcare professional \nIntended for professionals currently undergoing Specialized Health Training (FSE). Healthcare professionals who are currently pursuing an FSE specialty in any of the categories recognized by the Ministry of Health (MIR\, EIR\, FIR\, PIR\, BIR\, QIR\, and RFIR) are eligible to apply for this category.\nProfessionals in training who have developed or are currently developing initiatives or projects aimed at addressing any of the interests of the community served by our Federation—with a focus on people with lived experiences of liver disease\, their families\, and their communities—are eligible to apply. \n3. Research group in a field related to the organization’s mission \nIt recognizes teams that promote scientific knowledge about liver diseases\, as well as related issues such as the social\, occupational\, psychological\, or other impacts of these diseases.\nAny research group currently conducting a study in the aforementioned fields and affiliated with a research center or public university in Spain may apply for this category. \n4. Healthcare professionals in relevant fields \nThis award recognizes specialists who have distinguished themselves through their work in healthcare and comprehensive\, person-centered care. Special emphasis will be placed on these professionals’ ability to integrate the clinical needs with the psychosocial aspects of patients with liver disease and their families.\nActive professionals (in medicine\, nursing\, psychology\, health social work\, etc.) who work in public or private healthcare facilities throughout Spain are eligible for this award. Consideration will be given to the impact of their work on improving patients’ quality of life\, their collaboration with community organizations\, and their track record in humanizing patient care.\nApplications may be submitted by the candidate themselves or on behalf of a third party. In the latter case\, contact information for the third party must be provided. \n5. Promotion of Volunteerism \nThis award recognizes innovative programs or projects aimed at recruiting\, training\, managing\, and retaining volunteers within the nonprofit sector. This category highlights social commitment and solidarity as fundamental pillars for the sustainability of organizations that work with liver patients. \nThe cash prize will be awarded to the winning organization that develops and leads the volunteer program. The initiatives submitted must demonstrate how volunteer work has added value to patient care or raised public awareness about liver health. A report detailing the volunteer program’s activities must be submitted. \n6. Honorary Lifetime Achievement Award \nIt will recognize an individual who has distinguished themselves through their exceptional\, ongoing\, and selfless commitment to the liver patient community in Spain\, as well as through their contribution to supporting\, advocating for\, and improving the quality of life of those affected. \nThis special award represents the Federation’s highest recognition of a life and career marked by dedication to the community. As this is an honorary distinction\, any member association of the Federation may nominate a candidate. \n  \nCOMPLETE RULES FOR THE CALL FOR APPLICATIONS \n  \n  \n  URL:https://ibsal.es/en/evento/call-for-entries-eva-p-bech-awards-1st-edition-spanish-liver-federation/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20260701T000000 DTEND;TZID=Europe/Helsinki:20261001T130000 DTSTAMP:20260715T085851Z CREATED:20260715T085851Z LAST-MODIFIED:20260715T085851Z UID:10002356-1782864000-1790859600@ibsal.es SUMMARY:Call for Proposals: R&D Projects - Pilot Studies on Public Policy - MICIU DESCRIPTION:Purpose\nThe R&I Project Call seeks to fund projects that promote research and innovation\, as well as scientific advice in public administration\, using scientific evidence to develop more effective policies. \n  \nDescription\nA public policy pilot study is a structured approach to learning—defined before the pilot begins—designed to generate knowledge about a public policy instrument (organizational\, regulatory\, financial\, or information-based). Pilot projects submitted in this subcategory must include a work plan and a series of milestones against which their implementation will be assessed. This plan must take into account the time needed to draw conclusions from the pilot. \nThe pilot project may involve significantly modifying a public administration tool used in the project (redesign); adapting a tool that has proven effective in another public administration to determine whether it is transferable (replication); or introducing an innovative tool (new or with significant improvements) compared to existing tools. \nThe study may consist of: \n\nTest the implementation of a tool in a small-scale pilot. These exploratory pilots are conducted when it is believed that the tool can be implemented as planned\, but it is still necessary to see how it actually works in the partner organization. They aim to determine whether the instrument can be implemented as planned; how beneficiaries respond to the instrument (their behavior or level of acceptance); or what results are likely to be obtained. These exploratory pilot studies help identify problems in the design and implementation of the instrument and provide an opportunity to refine the planning and the approach to evaluating the results.\nThe methodology of scientific research may be based\, for example\, on observational methods. \nConduct a small-scale pilot study to assess whether an instrument achieves its expected results. Pilot studies can be used to evaluate results. The evaluation should have the potential to influence the design of the instrument.\nThe evaluation methodology may be based\, for example\, on quasi-experimental methods or on experimental methods in a controlled setting\, such as randomized trials. The design of the instrument being tested in the pilot must be sufficiently developed to allow for the design of a randomized trial. For example\, it is necessary to ensure a sufficient sample size of participants in an intervention by conducting a preliminary study of demand. Studies based on randomized trials must analyze their ethical implications. \n\n\n  \nBeneficiaries\nResearch organizations\, universities\, healthcare institutions\, technology centers\, R&D centers\, and other entities that promote the transfer of R&D. To participate\, projects must be supported by a letter from a public administration committing to collaborate on the project. \n  \nScope of Assistance and Duration\nThe assistance covers\, among other things\, items such as: \n\nPersonnel costs for staff hired specifically for the project.\nTravel and per diem expenses.\nProcurement of equipment and supplies.\nConsulting\, advisory services\, data collection\, development of training programs\, project evaluation\, dissemination\, and publicity.\nRoom rentals\, conference planning\, events…\n\nGrants of up to 90% of the total project cost are available\, with a maximum limit of €100\,000 and a total estimated budget of three million euros. The project duration is a maximum of 24 months. \n  \nDeadlines\nThe application period will begin on July 1\, 2026\, and end on October 1\, 2026\, at 1:00 p.m. (Spanish peninsular time). \n  \nSubmission of Applications\nApplications must be submitted through the online application system available at the call for proposals’ website. Project leaders and the legal representatives of the applicant organizations must first register in the call for proposals’ Applicant Registration module and complete the corresponding application form. \nApplications must include a letter of support from the government agency responsible for the public policy whose design is to be improved. \n  \nCALL FOR SUBMISSIONS WEBSITE URL:https://ibsal.es/en/evento/call-for-proposals-rd-projects-pilot-studies-on-public-policy-miciu/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/Helsinki:20260701T000000 DTEND;TZID=Europe/Helsinki:20261001T130000 DTSTAMP:20260715T085911Z CREATED:20260715T085911Z LAST-MODIFIED:20260715T085911Z UID:10002297-1782864000-1790859600@ibsal.es SUMMARY:Call for I+P Projects - Scientific research projects aimed at improving public policy design - MICIU DESCRIPTION:Purpose\nThe R&I Project Call seeks to fund projects that promote research and innovation\, as well as scientific advice in public administration\, using scientific evidence to develop more effective policies. \n  \nDescription\nA collaborative public administration can exchange knowledge with the requesting entity on a project that helps explore and better understand an issue that public policy seeks to address. This project would serve to update the assessment of the context of a public policy\, through\, for example\, foresight exercises or technology assessments. \nThe project may also aim to have the collaborating public administration review the rationale behind the intervention and its theory of change\, the objectives of the public policy\, or the selection of its instruments—for example\, through data mining and analysis. This data may be administrative data: the collaborating government agency may have data that it needs to organize\, analyze\, and integrate into a conceptual framework to guide the design of its public policies. Quasi-experimental methods\, for example\, may also be used to review the planning process. \n  \nBeneficiaries\nResearch organizations\, universities\, healthcare institutions\, technology centers\, R&D centers\, and other entities that promote the transfer of R&D. To participate\, projects must be supported by a letter from a public administration committing to collaborate on the project. \n  \nScope of Assistance and Duration\nThe assistance covers\, among other things\, items such as: \n\nPersonnel costs for staff hired specifically for the project.\nTravel and per diem expenses.\nProcurement of equipment and supplies.\nConsulting\, advisory services\, data collection\, development of training programs\, project evaluation\, dissemination\, and publicity.\nRoom rentals\, conference planning\, events…\n\nGrants of up to 90% of the total project cost are available\, with a maximum limit of €100\,000 and a total estimated budget of three million euros. The project duration is a maximum of 24 months. \n  \nDeadlines\nThe application period will begin on July 1\, 2026\, and end on October 1\, 2026\, at 1:00 p.m. (Spanish peninsular time). \n  \nSubmission of Applications\nApplications must be submitted through the online application system available at the call for proposals’ website. Project leaders and the legal representatives of the applicant organizations must first register in the call for proposals’ Applicant Registration module and complete the corresponding application form. \nApplications must include a letter of support from the government agency responsible for the public policy whose design is to be improved. \n  \nCALL FOR SUBMISSIONS WEBSITE URL:https://ibsal.es/en/evento/call-for-ip-projects-scientific-research-projects-aimed-at-improving-public-policy-design-miciu/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260716 DTEND;VALUE=DATE:20261116 DTSTAMP:20260717T081311Z CREATED:20260717T081311Z LAST-MODIFIED:20260717T081311Z UID:10002266-1784160000-1794787199@ibsal.es SUMMARY:“Salamanca Institute of Biomedical Research – Royal Academy of Medicine” Award DESCRIPTION:Description\nThe “Salamanca Biomedical Research Institute – Royal Academy of Medicine” Award for the best innovative work in health sciences conducted in 2026 by medical and non-medical professionals affiliated with the Salamanca Biomedical Research Institute (IBSAL). \n\n\n\n  \nAward\nThe prize consists of €1\,000 and a certificate. \n  \nPresentation\nTo submit an entry\, the candidate for the award must send the work and the relevant documentation (CVN and 3 copies of the work\, along with an electronic copy. In the case of multiple authors\, informed consent from all authors must be provided for the submission of the work to the award) for evaluation\, along with detailed information on the project’s current status. \nThe documents should be sent to the Academy’s email address\, ramsa@usal.es. \nThe documentation must be submitted by 1:00 p.m. on November 15\, 2026. \n  \nEvaluation\nThe judging panel\, composed of four Full Members of the RAMSA\, will issue its final evaluation based on the following criteria: the originality of the innovation—which may be basic\, clinical\, educational\, managerial\, etc.; its impact; other aspects that the committee deems relevant regarding the merits demonstrated by the author\, provided that they are related to the innovation. \n  \nRead the rules URL:https://ibsal.es/en/evento/salamanca-institute-of-biomedical-research-royal-academy-of-medicine-award/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260718 DTEND;VALUE=DATE:20260923 DTSTAMP:20260813T070323Z CREATED:20260813T070323Z LAST-MODIFIED:20260813T070323Z UID:10002358-1784332800-1790121599@ibsal.es SUMMARY:Call for Applications for Research Collaboration Scholarships at USAL Research Institutes and Affiliated Centers DESCRIPTION:Objective\nThe University of Salamanca is offering\, on a competitive basis\, 27 research assistantships at its research institutes and university-affiliated centers \nThese scholarships are intended to encourage students to begin engaging in research related to their current studies and to facilitate the future professional or research careers of students enrolled at the University of Salamanca during the 2026/2027 academic year who are about to complete their undergraduate degree or are currently enrolled in the first year of an official master’s program. \n  \nAmount\nThe amount of each scholarship is 2\,000 euros\, paid in a single installment\, which will be deposited into the bank account number provided for this purpose. Receipt of this scholarship does not exempt the recipient from paying the public fees for academic services. \nScholarship payments will be made from budget line 18.02.39.324M.D.07 of the University of Salamanca’s budget\, up to a maximum of 54\,000 euros. \n\n  \nDuration and Commitment\nThe collaboration will last seven and a half months from the start date indicated in the Resolution and will require three hours of on-site work per day\, in accordance with the terms set forth in the collaboration proposal submitted. \n  \nIncompatibilities\nThese scholarships are incompatible with any other scholarship or financial aid awarded for the current academic year by public or private organizations for the same or a similar purpose\, as well as with any contractual compensation that would prevent the fulfillment of the obligations. \nThey will be compatible with the general scholarships for the 2026–2027 academic year offered by the Ministry of Education\, Vocational Training\, and Sports for college students\, as well as with academic excellence programs. \n  \nApplications\nThe application must be completed using the form available on the University of Salamanca’s Online Portal\, by logging in with any of the authentication methods listed in the following online procedure (including IdUsal): \nhttps://sede.usal.es/procedimientos?param1=BECOIN \nThe applicant must ensure that the process is completed correctly and download the registered receipt. The process is complete when the following message appears on the online portal: “Process completed. You have completed all your tasks. Your application for Research Institute and University-Affiliated Center Collaboration Scholarships has been submitted for processing.” \nApplications that do not complete the established submission process will not be considered. Applicants must obtain the application receipt\, which must be retained to prove\, if necessary\, that the application was submitted within the established time frame and in the prescribed manner. \nIf the same person submits more than one scholarship application\, only the most recent one will be processed. \nNo changes to the application will be accepted after the application deadline has passed. \nApplicants may apply to a maximum of three different high schools or schools. \nSubmission of the application implies acceptance of the terms and conditions of the call for applications and\, specifically\, authorization for the publication of the provisional and final lists of candidates for the process\, including their grade point averages and the score awarded to the collaborative project\, as well as the location where the work will be performed and the amount of the grant awarded\, in accordance with the provisions of the regulations governing grants and the regulations on the protection of personal data. \n  \nSubmission Deadline\nThe application period will run from July 18\, 2026\, through September 22\, 2026\, inclusive. \n  \nCALL FOR APPLICATIONS \nBOCYL EXTRACT \n  \n  URL:https://ibsal.es/en/evento/call-for-applications-for-research-collaboration-scholarships-at-usal-research-institutes-and-affiliated-centers/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260720 DTEND;VALUE=DATE:20260921 DTSTAMP:20260722T093050Z CREATED:20260722T093050Z LAST-MODIFIED:20260722T093050Z UID:10002309-1784505600-1789948799@ibsal.es SUMMARY:Call for Proposals: Clinical Research and Medical Innovation - Duponte Program DESCRIPTION:Objective\nThe goal is to promote research projects with a significant impact on clinical practice that contribute to the advancement of personalized medicine\, with a particular focus on genomic alterations and the development of new technologies and therapeutic strategies. \n  \nParticipants\nThis call for proposals is open to universities\, hospitals\, and facilities within the National Health System\, as well as research centers and institutes and biotechnology companies. \n  \nPriority Areas\nThe priority areas for research projects are as follows: \n— Genomics \n— Bioinformatics \n— Clinical Pharmacogenomics \n— Rare Diseases \n  \nImportant Dates\nApplication period begins: 20/07/2026 \nApplication deadline: September 20\, 2026 \nResolution: October 2026 \n  \nApplication Process\nTo access the application\, you must do so through the call for applications website byclicking”here.” \nOr by visiting: https://www.duponteconvoca.com/ \nThe process consists of three steps: \n1. Complete the registration as Principal Investigator and attach your resume. \n2. Submit the proposal by accessing your profile and completing the proposal with all the required documentation. \n3. Receive the results: The proposal will be reviewed by independent experts based on scientific\, technical\, clinical\, and regulatory criteria. \n  \nCALL FOR SUBMISSIONS WEBSITE URL:https://ibsal.es/en/evento/call-for-proposals-clinical-research-and-medical-innovation-duponte-program/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260925 DTEND;VALUE=DATE:20260926 DTSTAMP:20260804T112341Z CREATED:20260310T074503Z LAST-MODIFIED:20260804T112341Z UID:10002327-1790294400-1790380799@ibsal.es SUMMARY:3rd Clinical Simulation Conference in Cardiology\, Castile and León 2026 DESCRIPTION:In-Person Conference: “3rd Clinical Simulation Conference in Cardiology\, Castile and León 2026” \n  \nObjective: \nTraining in critical cardiac care using clinical simulation\, through hands-on workshops and clinical cases. \n  \nSpecific objectives: \nTraining in non-technical skills\, basic and advanced cardiopulmonary resuscitation\, airway management\, mechanical ventilation\, vasoactive medications\, mechanical circulatory support\, and renal replacement therapy. \nDate: \nFriday\, September 25\, 2026. \n  \nLocation: \nAdvanced Clinical Simulation Center\nPontifical University of Salamanca\nSalamanca (Spain). \n  \nProgram: \n \nEnrollment: \nREGISTRATION: \nThe registration deadline is Monday\, September 21\, 2026; you must register individually through our website. \nIn order to successfully complete the course and receive the relevant certificate\, it is necessary to complete 80% of the total program. \n  \nPrice: \n100 euros. \n  \nMethod of selection: \nEnrollment in the course will be carried out in strict order of enrollment (in courses with high demand\, preference will be given to IBSAL personnel)\, according to the agreement of the IBSAL Training Commission. \n  URL:https://ibsal.es/en/evento/3rd-clinical-simulation-conference-in-cardiology-castile-and-leon-2026/ LOCATION:Advanced Clinical Simulation Center\, Pontifical University of Salamanca\, Salamanca (Spain)\, 5 Compañía Street\, Salamanca\, Salamanca\, 37006\, Spain CATEGORIES:Sacyl Course END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20261019 DTEND;VALUE=DATE:20261020 DTSTAMP:20260724T062722Z CREATED:20260724T062722Z LAST-MODIFIED:20260724T062722Z UID:10002257-1792368000-1792454399@ibsal.es SUMMARY:FERO Cancer Calls for Proposals 2027 DESCRIPTION:Objective\nThe goal of these calls for proposals is to promote translational cancer research projects and support researchers at various stages of their scientific careers in order to accelerate advances that will transform the future of cancer. \n  \nHelp\n— FERO Cancer Fellowship for Young Researchers 2027\n— FERO Cancer Fellowship for Young Medical Researchers 2027\n— Dr. Josep Baselga FERO Cancer Scholarship 2027\n— FERO Pediatric Cancer Scholarship 2027\n— FERO Women’s Cancer Grant 2027\, for projects focused on cancers that affect women. (NEW) \n— FERO Lung Cancer Grant – The Ricky Rubio Foundation 2027\, a new call for proposals to accelerate lung cancer research. (NEW) \n  \nDeadlines\nThe call for applications is not yet open. The application period begins on October 19\, 2026; the closing date has not yet been set. An “info day” will be held to finalize the details. \n  \nInfo Day\nIn order to present the new features of this edition\, explain the changes made to the guidelines\, share the new schedule\, and answer any questions about the application process\, an Info Day will be held for researchers and institutions. \n\nDate: September 29\, 2026\nTime: 11:00 a.m.–12:00 p.m.\nFormat: Online\n\nThose interested can register via the following link to gain access to the session:\nhttps://forms.office.com/e/0JLwjfjHvg?origin=lprLink \nIf you have any questions\, please contact beca@ferocancer.org URL:https://ibsal.es/en/evento/fero-cancer-calls-for-proposals-2027/ CATEGORIES:Calls for research END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20270210 DTEND;VALUE=DATE:20270923 DTSTAMP:20260513T105706Z CREATED:20260513T105706Z LAST-MODIFIED:20260513T105706Z UID:10002229-1802217600-1821657599@ibsal.es SUMMARY:Horizon Europe. Cluster 1: Health 2027 DESCRIPTION:Features\nThe work program for Cluster 1 (Health) under Horizon Europe has been published: Horizon Europe Cluster 1 Health Work Program for 2027. It falls within the framework of the new Horizon Europe strategic plan for the 2025–2027 period. The main priorities focus on social cohesion\, inclusion\, and the overall health and well-being of Europeans\, in line with the European Pillar of Social Rights. Other key priorities include the need to modernize health care systems and to support an innovative\, sustainable\, and competitive health industry in Europe. \nMore specifically\, Cluster 1 strives to contribute to six expected impacts as set forth in the Strategic Plan\, which are distributed across the following topics: \nList of calls for applications that open on February 10\, 2027\, and close on April 13\, 2027: \n\nDestination – Staying Healthy in a Rapidly Changing Society \nHORIZON-HLTH-2027-01-STAYHLTH-01: Addressing Disabilities Throughout the Life Course to Support Independent Living and Inclusion \nDestination – Living and Working in a Health-Promoting Environment \nHORIZON-HLTH-2027-01-ENVHLTH-02: Integrating climate-related exposures into the human exposome and characterizing its changes in response to climate change \nHORIZON-HLTH-2027-01-ENVHLTH-MISSCLIMA-03: Tools and technologies to support health adaptation to climate change \nDestination – Tackling Diseases and Reducing the Disease Burden \nHORIZON-HLTH-2027-01-DISEASE-05: Development of novel small-molecule antiviral therapeutics for pathogens with epidemic potential \nHORIZON-HLTH-2027-01-DISEASE-06: Development of Monoclonal Antibodies to Prevent and Treat Infections Caused by Flaviviruses \nHORIZON-HLTH-2027-01-DISEASE-07: Development of monoclonal antibodies to prevent and treat infections caused by Filo-\, Nairo-\, Phenui-\, Picorna-\, and Toga viruses \nHORIZON-HLTH-2027-01-DISEASE-08: Development of Innovative Antimicrobials Against Antimicrobial-Resistant Pathogens \nHORIZON-HLTH-2027-01-DISEASE-10: Prevention and Management of Chronic Noncommunicable Diseases in Children and Young People (GACD) \nDestination – Ensuring equal access to innovative\, sustainable\, and high-quality healthcare \nHORIZON-HLTH-2027-01-CARE-02: Personalized Approaches to Reduce Risks from Adverse Drug Reactions Resulting from the Administration of Multiple Medications \n\nDestination – Maintaining an innovative\, sustainable\, and competitive EU healthcare industry \nHORIZON-HLTH-2027-01-IND-01: Development of cell-free protein synthesis platforms for the discovery and/or production of biologics \n  \nList of two-phase calls for proposals opening on February 10\, 2027. The first phase closes on April 13\, 2027\, and the second phase closes on September 22\, 2027: \nDestination – Tackling Diseases and Reducing the Disease Burden \nHORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for noncommunicable diseases \nHORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials to advance innovative interventions for neurodegenerative diseases \nDestination – Developing and using new tools\, technologies\, and digital solutions for a healthy society \nHORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers for disease progression and treatment response using AI methodologies for chronic noncommunicable diseases \nDestination – Maintaining an innovative\, sustainable\, and competitive EU healthcare industry \nHORIZON-HLTH-2027-02-IND-02-two-stage: Portable and Versatile Point-of-Care Diagnostics \n  \nList of calls for applications that open on June 3\, 2027\, and close on September 22\, 2027: \nDestination – Developing and using new tools\, technologies\, and digital solutions for a healthy society \nHORIZON-HLTH-2027-03-TOOL-02: Advancing the bioprinting of living cells for regenerative medicine \nHORIZON-HLTH-2027-03-TOOL-04: Virtual Human Twins (VHTs) for Integrated Clinical Decision Support in Prevention and Diagnosis \nHORIZON-HLTH-2027-03-TOOL-08: Toward Artificial General Intelligence (AGI) for Healthcare \n  \n**If you’re interested in any of our job openings or need more information\, please don’t hesitate to contact us. \n\n\n\nRequirements:\nThese calls for proposals are aimed at multidisciplinary European consortia. Unless otherwise specified in the specific conditions of the call\, only legal entities that form a consortium will be eligible to participate in the actions\, provided that the consortium includes\, as beneficiaries\, three legal entities that are independent of one another\, each established in a different country\, in accordance with the following criteria: \n\n\nat least one independent legal entity established in a Member State; and \n\n\nat least two other independent legal entities\, each established in different Member States or Associated Countries. \n\n\nLegal entities established in Russia\, Belarus\, or in territories of Ukraine not controlled by the government are not eligible. \nHow to apply\nApplications consist of two sections: \n-Part A (to be completed online) contains administrative information related to the consortium\, the budget\, and specific details of the call for proposals. \n-Part B (a template downloaded from the Commission’s website must be completed) contains the scientific and technical aspects of the project. URL:https://ibsal.es/en/evento/horizon-europe-cluster-1-health-2027/ CATEGORIES:Calls for research END:VEVENT END:VCALENDAR